Global PLK Targeted Therapies Market Opportunity & Clinical
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Dna Damage Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The
Germany's Merck KGaA on Monday said it struck a collaboration deal with Chinese drugmaker Jiangsu Hengrui Pharmaceuticals to widen Merck's work in an area known as "DNA damage response" drugs. In a statement on Monday, diversified group Merck said it agreed to pay Hengrui 160 million euros ($169 million) upfront. The deal could be worth up to 1.4 billion euros when including payments contingent on development and commercial achievement as well as royalties on sales.
Biochemical assays for key enzymes in the innate immunity and DNA damage response (DDR) pathways
Mechanisms that help repair DNA damage block the healing of nerves after an injury. Using a drug that can block this mechanism fosters recovery.